Association between vaccination and Guillain-Barré syndrome

The Lancet Infectious Diseases

Volumn 13, Issue 9, 2013, Pages 730-731

  Tomljenovic, Lucija ^a,b   Shoenfeld, Yehuda ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADVERSE OUTCOME; ARTHRALGIA; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; LATENT PERIOD; LETTER; MEDICAL DOCUMENTATION; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; WEAKNESS;

FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; VACCINATION;

EID: 84882585215     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70142-7     Document Type: Letter

References (13)

1. Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y Guillain-Barré syndrome-a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol 2012, 42:121-130.
2. Rees JH, Thompson RD, Smeeton NC, Hughes RA Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry 1998, 64:74-77.
3. Rajabally YA, Uncini A Outcome and its predictors in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2012, 83:711-718.
4. Nachamkin I, Shadomy SV, Moran AP, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis 2008, 198:226-233.
5. Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 1984, 119:841-879.
6. Kwong JC, Vasa PP, Campitelli MA, et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013, published online June 28. http://dx.doi.org/10.1016/S1473-3099(13)70104-X.
7. Andrews N, Stowe J, Al-Shahi Salman R, Miller E Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 2011, 29:7878-7882.
8. Burwen DR, Ball R, Bryan WW, et al. Evaluation of Guillain-Barré syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010, 39:296-304.
9. Greene SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain-Barré syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol 2012, 175:1100-1109.
10. Mikaeloff Y, Caridade G, Suissa S, Tardieu M Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009, 72:873-880.
11. Poser CM, Behan PO Late onset of Guillain-Barré syndrome. J Neuroimmunol 1982, 3:27-41.
12. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5:648-652.
13. Quiroz-Rothe E, Ginel PJ, Pérez J, Lucena R, Rivero JLL Vaccine-associated acute polyneuropathy resembling Guillain-Barré syndrome in a dog. EJCAP 2005, 15:155-159.